Mu-Yang Huang, Yu-Chi Chen, Wen-Yu Lyu, Xin-Yu He, Zi-Han Ye, Can-Yu Huang, . . . Jin-Jian Lu. (2023). Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10. Elsevier.
Chicago Style (17th ed.) CitationMu-Yang Huang, et al. Ginsenoside Rh2 Augmented Anti-PD-L1 Immunotherapy by Reinvigorating CD8+ T Cells via Increasing Intratumoral CXCL10. Elsevier, 2023.
MLA (9th ed.) CitationMu-Yang Huang, et al. Ginsenoside Rh2 Augmented Anti-PD-L1 Immunotherapy by Reinvigorating CD8+ T Cells via Increasing Intratumoral CXCL10. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.